C. Miret

发表

Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.

G. Espinosa, J. Font, R. Cervera, 1997, Clinical and experimental rheumatology.

Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.

M. García-Carrasco, R. Molina, J. Font, 2001, Anticancer research.

Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy

J. Barberà, F. Muñoz-Rodríguez, J. Font, 1997, Lupus.

Visual impairment in a woman with histiocytosis.

E. Pedrol, A. Coca, A. Urbano-Márquez, 1995, Postgraduate medical journal.

Lack of relationship between human immunodeficiency virus infection and systemic lupus erythematosus

R. Cervera, J. Font, R. Cervera, 1995, Lupus.

Bcl-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemic lupus erythematosus disease activity.

M. García-Carrasco, R. Molina, J. Font, 1999, Anticancer Research.

Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients.

M. García-Carrasco, G. Espinosa, J. Font, 1997, Clinical and experimental rheumatology.

Antibodies to thromboplastin in systemic lupus erythematosus: isotype distribution and clinical significance in a series of 92 patients.

R. Cervera, J. Font, R. Cervera, 1997, Thrombosis Research.

[Primary Sjögren's syndrome: clinical and immunologic study of 80 patients].

M. García-Carrasco, G. Espinosa, J. Font, 1997, Medicina clinica.

IgA nephropathy associated with eosinophilic fasciitis: report of a case.

R. Cervera, M. Torres, F. Nonell, 2003, Clinical and experimental rheumatology.

Relationship of p53 with other Oncogenes, Cytokines and Systemic Lupus Erythematosus Activity

M. García-Carrasco, R. Molina, J. Font, 2003, Tumor Biology.

Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome?

M. García-Carrasco, R. Cervera, J. Font, 1997, Clinical and experimental rheumatology.